Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR - 50% reduction in osteoarthritis pain maintained

Jun 15, 2018 at 2:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment